Global Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029

Publisher TechNavio

Published Jul 17, 2025

Length 229 Pages

SKU # INF20221533

Description

Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029

The chronic obstructive pulmonary disease drugs market is forecasted to grow by USD 7841 mn during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the chronic obstructive pulmonary disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of copd, strong pipeline and new drug approvals, and growing demand for fixed-dose combinations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's chronic obstructive pulmonary disease drugs market is segmented as below:

By Product

Combination therapy
Monotherapy

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Route Of Administration

Inhalation
Oral
Injectable

By Disease Type

Chronic bronchitis
Emphysema

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expanding research in curative approaches as one of the prime reasons driving the chronic obstructive pulmonary disease drugs market growth during the next few years. Also, advances in drug delivery devices and expansion of inhalation therapies will lead to sizable demand in the market.

The report on the chronic obstructive pulmonary disease drugs market covers the following areas:

Chronic Obstructive Pulmonary Disease Drugs Market sizing
Chronic Obstructive Pulmonary Disease Drugs Market forecast
Chronic Obstructive Pulmonary Disease Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic obstructive pulmonary disease drugs market vendors that include AstraZeneca Plc, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CHIESI Farmaceutici SpA, Cipla Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Innoviva Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, SHIONOGI Co. Ltd., Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Theravance Biopharma Inc., Viatris Inc., and Phillips Medisize. Also, the chronic obstructive pulmonary disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by Disease Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023; Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023 ($ million); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ million); 5.3 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.4 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); 5.5 Disease Type segment analysis 2019 - 2023; Historic Market Size - Disease Type Segment 2019 - 2023 ($ million); 5.6 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.7 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 The AI impact on Global Chronic Obstructive Pulmonary Disease Drugs Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Combination therapy - Market size and forecast 2024-2029; Chart on Combination therapy - Market size and forecast 2024-2029 ($ million); Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million); Chart on Combination therapy - Year-over-year growth 2024-2029 (%); Data Table on Combination therapy - Year-over-year growth 2024-2029 (%); 8.4 Monotherapy - Market size and forecast 2024-2029; Chart on Monotherapy - Market size and forecast 2024-2029 ($ million); Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million); Chart on Monotherapy - Year-over-year growth 2024-2029 (%); Data Table on Monotherapy - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Distribution Channel: 9.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 9.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 9.3 Hospital pharmacies - Market size and forecast 2024-2029; Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%); 9.4 Retail pharmacies - Market size and forecast 2024-2029; Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); 9.5 Online pharmacies - Market size and forecast 2024-2029; Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Online pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration: 10.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 10.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 10.3 Inhalation - Market size and forecast 2024-2029; Chart on Inhalation - Market size and forecast 2024-2029 ($ million); Data Table on Inhalation - Market size and forecast 2024-2029 ($ million); Chart on Inhalation - Year-over-year growth 2024-2029 (%); Data Table on Inhalation - Year-over-year growth 2024-2029 (%); 10.4 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ million); Data Table on Oral - Market size and forecast 2024-2029 ($ million); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 10.5 Injectable - Market size and forecast 2024-2029; Chart on Injectable - Market size and forecast 2024-2029 ($ million); Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Chart on Injectable - Year-over-year growth 2024-2029 (%); Data Table on Injectable - Year-over-year growth 2024-2029 (%); 10.6 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by Disease Type: 11.1 Market segments; Chart on Disease Type - Market share 2024-2029 (%); Data Table on Disease Type - Market share 2024-2029 (%); 11.2 Comparison by Disease Type; Chart on Comparison by Disease Type; Data Table on Comparison by Disease Type; 11.3 Chronic bronchitis - Market size and forecast 2024-2029; Chart on Chronic bronchitis - Market size and forecast 2024-2029 ($ million); Data Table on Chronic bronchitis - Market size and forecast 2024-2029 ($ million); Chart on Chronic bronchitis - Year-over-year growth 2024-2029 (%); Data Table on Chronic bronchitis - Year-over-year growth 2024-2029 (%); 11.4 Emphysema - Market size and forecast 2024-2029; Chart on Emphysema - Market size and forecast 2024-2029 ($ million); Data Table on Emphysema - Market size and forecast 2024-2029 ($ million); Chart on Emphysema - Year-over-year growth 2024-2029 (%); Data Table on Emphysema - Year-over-year growth 2024-2029 (%); 11.5 Market opportunity by Disease Type; Market opportunity by Disease Type ($ million); Data Table on Market opportunity by Disease Type ($ million)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape: 13.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 13.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 13.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 13.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 13.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 13.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 13.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 13.8 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 13.9 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 13.10 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 13.11 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 13.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 13.13 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 13.14 Spain - Market size and forecast 2024-2029; Chart on Spain - Market size and forecast 2024-2029 ($ million); Data Table on Spain - Market size and forecast 2024-2029 ($ million); Chart on Spain - Year-over-year growth 2024-2029 (%); Data Table on Spain - Year-over-year growth 2024-2029 (%); 13.15 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ million); Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 13.16 The Netherlands - Market size and forecast 2024-2029; Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); 13.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints: 14.1 Market drivers; 14.2 Market challenges; 14.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 14.4 Market opportunities/restraints
15 Competitive Landscape: 15.1 Overview; 15.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 15.3 Landscape disruption; Overview on factors of disruption; 15.4 Industry risks; Impact of key risks on business
16 Competitive Analysis: 16.1 Companies profiled; Companies covered; 16.2 Company ranking index; Company ranking index; 16.3 Market positioning of companies; Matrix on companies position and classification; 16.4 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 16.5 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; SWOT; 16.6 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; SWOT; 16.7 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; SWOT; 16.8 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 16.9 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 16.10 Innoviva Inc.; Innoviva Inc. - Overview; Innoviva Inc. - Product / Service; Innoviva Inc. - Key news; Innoviva Inc. - Key offerings; SWOT; 16.11 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; SWOT; 16.12 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 16.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 16.14 SHIONOGI Co. Ltd.; SHIONOGI Co. Ltd. - Overview; SHIONOGI Co. Ltd. - Product / Service; SHIONOGI Co. Ltd. - Key offerings; SWOT; 16.15 Sumitomo Pharma Co. Ltd.; Sumitomo Pharma Co. Ltd. - Overview; Sumitomo Pharma Co. Ltd. - Business segments; Sumitomo Pharma Co. Ltd. - Key offerings; Sumitomo Pharma Co. Ltd. - Segment focus; SWOT; 16.16 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT; 16.17 Theravance Biopharma Inc.; Theravance Biopharma Inc. - Overview; Theravance Biopharma Inc. - Product / Service; Theravance Biopharma Inc. - Key offerings; SWOT; 16.18 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; SWOT
17 Appendix: 17.1 Scope of the report; 17.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 17.3 Currency conversion rates for US$; Currency conversion rates for US$; 17.4 Research methodology; Research methodology; 17.5 Data procurement; Information sources; 17.6 Data validation; Data validation; 17.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 17.8 Data synthesis; Data synthesis; 17.9 360 degree market analysis; 360 degree market analysis; 17.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits8: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibits9: Executive Summary - Chart on Incremental Growth; Exhibits10: Executive Summary - Data Table on Incremental Growth; Exhibits11: Executive Summary - Chart on Company Market Positioning; Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits13: Overview on criticality of inputs and factors of differentiation; Exhibits14: Overview on factors of disruption; Exhibits15: Impact of drivers and challenges in 2024 and 2029; Exhibits16: Parent Market; Exhibits17: Data Table on - Parent Market; Exhibits18: Market characteristics analysis; Exhibits19: Value chain analysis; Exhibits20: Offerings of companies included in the market definition; Exhibits21: Market segments; Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits26: Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Product Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million); Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits33: Five forces analysis - Comparison between 2024 and 2029; Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits39: Chart on Market condition - Five forces 2024 and 2029; Exhibits40: Chart on Product - Market share 2024-2029 (%); Exhibits41: Data Table on Product - Market share 2024-2029 (%); Exhibits42: Chart on Comparison by Product; Exhibits43: Data Table on Comparison by Product; Exhibits44: Chart on Combination therapy - Market size and forecast 2024-2029 ($ million); Exhibits45: Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million); Exhibits46: Chart on Combination therapy - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Combination therapy - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Monotherapy - Market size and forecast 2024-2029 ($ million); Exhibits49: Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million); Exhibits50: Chart on Monotherapy - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Monotherapy - Year-over-year growth 2024-2029 (%); Exhibits52: Market opportunity by Product ($ million); Exhibits53: Data Table on Market opportunity by Product ($ million); Exhibits54: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits55: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits56: Chart on Comparison by Distribution Channel; Exhibits57: Data Table on Comparison by Distribution Channel; Exhibits58: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits59: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits60: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Exhibits62: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits63: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits64: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits65: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits66: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits67: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits68: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%); Exhibits70: Market opportunity by Distribution Channel ($ million); Exhibits71: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits72: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits73: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits74: Chart on Comparison by Route of Administration; Exhibits75: Data Table on Comparison by Route of Administration; Exhibits76: Chart on Inhalation - Market size and forecast 2024-2029 ($ million); Exhibits77: Data Table on Inhalation - Market size and forecast 2024-2029 ($ million); Exhibits78: Chart on Inhalation - Year-over-year growth 2024-2029 (%); Exhibits79: Data Table on Inhalation - Year-over-year growth 2024-2029 (%); Exhibits80: Chart on Oral - Market size and forecast 2024-2029 ($ million); Exhibits81: Data Table on Oral - Market size and forecast 2024-2029 ($ million); Exhibits82: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits83: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits84: Chart on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits85: Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits86: Chart on Injectable - Year-over-year growth 2024-2029 (%); Exhibits87: Data Table on Injectable - Year-over-year growth 2024-2029 (%); Exhibits88: Market opportunity by Route of Administration ($ million); Exhibits89: Data Table on Market opportunity by Route of Administration ($ million); Exhibits90: Chart on Disease Type - Market share 2024-2029 (%); Exhibits91: Data Table on Disease Type - Market share 2024-2029 (%); Exhibits92: Chart on Comparison by Disease Type; Exhibits93: Data Table on Comparison by Disease Type; Exhibits94: Chart on Chronic bronchitis - Market size and forecast 2024-2029 ($ million); Exhibits95: Data Table on Chronic bronchitis - Market size and forecast 2024-2029 ($ million); Exhibits96: Chart on Chronic bronchitis - Year-over-year growth 2024-2029 (%); Exhibits97: Data Table on Chronic bronchitis - Year-over-year growth 2024-2029 (%); Exhibits98: Chart on Emphysema - Market size and forecast 2024-2029 ($ million); Exhibits99: Data Table on Emphysema - Market size and forecast 2024-2029 ($ million); Exhibits100: Chart on Emphysema - Year-over-year growth 2024-2029 (%); Exhibits101: Data Table on Emphysema - Year-over-year growth 2024-2029 (%); Exhibits102: Market opportunity by Disease Type ($ million); Exhibits103: Data Table on Market opportunity by Disease Type ($ million); Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits107: Chart on Geographic comparison; Exhibits108: Data Table on Geographic comparison; Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on UK - Market size and forecast 2024-2029 ($ million)

Search Inside Report

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now